C84.7A
Billable codeAnaplastic large cell lymphoma, ALK-negative, breast
The ICD-10 code for anaplastic large cell lymphoma, alk-negative, breast is C84.7A.
Clinical notes
Also known as
Alternate wording, synonyms, or specific conditions that fall under this code, listed to help confirm you've picked the right one.
- Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)
Documentation support
General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.
- •If the associated manifestation or related condition noted above is also documented, an additional code should be reported alongside this one.
- •As a general rule, code to the highest level of specificity supported by the documentation in the medical record.
Related codes in this category
- C84.70Anaplastic large cell lymphoma, ALK-negative, unspecified site
- C84.71Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck
- C84.72Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes
- C84.73Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes
- C84.74Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb
- C84.75Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb
- C84.76Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes
- C84.77Anaplastic large cell lymphoma, ALK-negative, spleen
- C84.78Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites
- C84.79Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites
- C84.7BAnaplastic large cell lymphoma, ALK-negative, in remission
- C84.7AAnaplastic large cell lymphoma, ALK-negative, breast
Associated MS-DRGs
C84.7A can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.
Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.
- DRG 814Reticuloendothelial and Immunity Disorders with MCC
- DRG 815Reticuloendothelial and Immunity Disorders with CC
- DRG 816Reticuloendothelial and Immunity Disorders without CC/MCC
- DRG 820Lymphoma and Leukemia with Major O.R. Procedures with MCC
- DRG 821Lymphoma and Leukemia with Major O.R. Procedures with CC
- DRG 822Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC
- DRG 823Lymphoma and Non-Acute Leukemia with Other Procedures with MCC
- DRG 824Lymphoma and Non-Acute Leukemia with Other Procedures with CC
- DRG 825Lymphoma and Non-Acute Leukemia with Other Procedures without CC/MCC
- DRG 840Lymphoma and Non-Acute Leukemia with MCC
- DRG 841Lymphoma and Non-Acute Leukemia with CC
- DRG 842Lymphoma and Non-Acute Leukemia without CC/MCC